DK1114641T3 - Fluorethersammensætninger og metoder til inhibering af deres nedbrydning i nærværelse af en Lewis-syre - Google Patents

Fluorethersammensætninger og metoder til inhibering af deres nedbrydning i nærværelse af en Lewis-syre

Info

Publication number
DK1114641T3
DK1114641T3 DK01107733T DK01107733T DK1114641T3 DK 1114641 T3 DK1114641 T3 DK 1114641T3 DK 01107733 T DK01107733 T DK 01107733T DK 01107733 T DK01107733 T DK 01107733T DK 1114641 T3 DK1114641 T3 DK 1114641T3
Authority
DK
Denmark
Prior art keywords
inhibiting
degradation
methods
lewis acid
fluoroether
Prior art date
Application number
DK01107733T
Other languages
Danish (da)
English (en)
Inventor
Christopher Bieniarz
Rajagopalan Raghavan
Steve H Chang
Shuyen L Huang
Toshikazu Kawai
Manami Kobayashi
David Loffredo
Earl R Speicher
Keith R Cromack
Honorate A Stelmach
Original Assignee
Abbott Lab
Central Glass Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=25148366&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=DK1114641(T3) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Abbott Lab, Central Glass Co Ltd filed Critical Abbott Lab
Application granted granted Critical
Publication of DK1114641T3 publication Critical patent/DK1114641T3/da

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/02Inorganic compounds
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/075Ethers or acetals
    • A61K31/08Ethers or acetals acyclic, e.g. paraformaldehyde
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/10Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/12Carboxylic acids; Salts or anhydrides thereof
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/14Esters of carboxylic acids, e.g. fatty acid monoglycerides, medium-chain triglycerides, parabens or PEG fatty acid esters
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P23/00Anaesthetics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/0012Galenical forms characterised by the site of application
    • A61K9/0019Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Epidemiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Inorganic Chemistry (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Anesthesiology (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medical Preparation Storing Or Oral Administration Devices (AREA)
  • Catalysts (AREA)
  • Steroid Compounds (AREA)
DK01107733T 1997-01-27 1998-01-23 Fluorethersammensætninger og metoder til inhibering af deres nedbrydning i nærværelse af en Lewis-syre DK1114641T3 (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US08/789,679 US5990176A (en) 1997-01-27 1997-01-27 Fluoroether compositions and methods for inhibiting their degradation in the presence of a Lewis acid
EP98902707A EP0967975B1 (en) 1997-01-27 1998-01-23 Fluoroether compositions and methods for inhibiting their degradation in the presence of a lewis acid

Publications (1)

Publication Number Publication Date
DK1114641T3 true DK1114641T3 (da) 2006-05-15

Family

ID=25148366

Family Applications (2)

Application Number Title Priority Date Filing Date
DK01107733T DK1114641T3 (da) 1997-01-27 1998-01-23 Fluorethersammensætninger og metoder til inhibering af deres nedbrydning i nærværelse af en Lewis-syre
DK98902707T DK0967975T3 (da) 1997-01-27 1998-01-23 Fluorethersammensætninger og fremgangsmåde til at inhibere nedbrydningen af disse i nærværelse af en Lewis-syre

Family Applications After (1)

Application Number Title Priority Date Filing Date
DK98902707T DK0967975T3 (da) 1997-01-27 1998-01-23 Fluorethersammensætninger og fremgangsmåde til at inhibere nedbrydningen af disse i nærværelse af en Lewis-syre

Country Status (27)

Country Link
US (6) US5990176A (enExample)
EP (2) EP0967975B1 (enExample)
JP (5) JP3183520B2 (enExample)
KR (1) KR100368672B1 (enExample)
CN (3) CN1321958C (enExample)
AR (2) AR011090A1 (enExample)
AT (2) ATE320798T1 (enExample)
AU (1) AU726733B2 (enExample)
BG (2) BG109751A (enExample)
BR (1) BR9806996A (enExample)
CA (2) CA2626424A1 (enExample)
CO (1) CO4920220A1 (enExample)
CZ (1) CZ297092B6 (enExample)
DE (2) DE69800928T2 (enExample)
DK (2) DK1114641T3 (enExample)
ES (2) ES2256104T3 (enExample)
GR (1) GR3036190T3 (enExample)
HU (1) HUP0002101A3 (enExample)
IL (1) IL130150A (enExample)
NO (1) NO993606L (enExample)
NZ (1) NZ335994A (enExample)
PL (1) PL334477A1 (enExample)
PT (2) PT1114641E (enExample)
SK (1) SK284243B6 (enExample)
TR (1) TR199901579T2 (enExample)
WO (1) WO1998032430A1 (enExample)
ZA (1) ZA98418B (enExample)

Families Citing this family (23)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5990176A (en) * 1997-01-27 1999-11-23 Abbott Laboratories Fluoroether compositions and methods for inhibiting their degradation in the presence of a Lewis acid
US20030200963A1 (en) * 1998-01-09 2003-10-30 Flament-Garcia Mary Jane Container for an inhalation anesthetic
US6162443A (en) * 1998-01-09 2000-12-19 Abbott Laboratories Container for an inhalation anesthetic
US6074668A (en) * 1998-01-09 2000-06-13 Abbott Laboratories Container for an inhalation anesthetic
US6979456B1 (en) 1998-04-01 2005-12-27 Jagotec Ag Anticancer compositions
AU759641B2 (en) 1998-08-19 2003-04-17 Skyepharma Canada Inc. Injectable aqueous dispersions of propofol
EP1439677B9 (en) 1999-01-08 2007-11-07 Sony Deutschland GmbH Synchronisation symbol structure for an OFDM system
TW523409B (en) * 2000-09-15 2003-03-11 Baxter Int Container for inhalation anesthetic
BR0303489A (pt) * 2003-09-10 2005-07-05 Cristalia Prod Quimicos Farm Composição farmacêutica estabilizada de composto flúor-éter e método para inibir a degradação de composto flúor-éter. uso de agente estabilizante para inibir a degradação de composto flúor éter
MXPA06000803A (es) * 2003-09-10 2006-08-23 Cristalia Prod Quimicos Farm Composicion farmaceutica estable del compuesto de fluoroeter para uso anestesico, metodo para estabilizar un compuesto de fluoroeter, uso del agente estabilizador para evitar la degradacion de un compuesto de fluoroeter.
WO2006113636A2 (en) * 2005-04-18 2006-10-26 Minrad Inc. Preparation of sevoflurane with negligible water content
WO2009049460A1 (en) * 2007-10-15 2009-04-23 Jiangsu Hengrui Medicine Co., Ltd. New packaging material for sevoflurane
AU2009206390B2 (en) * 2008-01-22 2014-10-30 The Board Of Regents Of The University Of Texas System Volatile anesthetic compositions comprising extractive solvents for regional anesthesia and/or pain relief
US20090275785A1 (en) * 2008-05-01 2009-11-05 Barry Jones Distillation Method For The Purification Of Sevoflurane And The Maintenance Of Certain Equipment That May Be Used In The Distillation Process
US8563115B2 (en) * 2008-08-12 2013-10-22 Xerox Corporation Protective coatings for solid inkjet applications
US8092822B2 (en) * 2008-09-29 2012-01-10 Abbott Cardiovascular Systems Inc. Coatings including dexamethasone derivatives and analogs and olimus drugs
US8283643B2 (en) * 2008-11-24 2012-10-09 Cymer, Inc. Systems and methods for drive laser beam delivery in an EUV light source
US8191992B2 (en) * 2008-12-15 2012-06-05 Xerox Corporation Protective coatings for solid inkjet applications
US9278048B2 (en) * 2009-05-06 2016-03-08 Baxter International, Inc. Pharmaceutical product and method of use
US9102604B1 (en) 2010-02-15 2015-08-11 Baxter International Inc. Methods for cleaning distilling columns
CN105106182B (zh) * 2015-09-21 2017-12-29 山东新时代药业有限公司 七氟烷吸入剂
CN105193774B (zh) * 2015-09-21 2018-01-16 山东新时代药业有限公司 一种七氟烷吸入剂
CA2952552C (en) 2016-11-02 2018-05-15 Central Glass Company, Limited Method for washing sevoflurane storage container and method for storing sevoflurane

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2992276A (en) * 1959-05-20 1961-07-11 Du Pont Process for preparing polyfluoro alkyl compounds
US3527813A (en) * 1966-10-03 1970-09-08 Air Reduction 1,1,2 - trifluoro - 2 - chloroethyl difluoromethyl ether and its method of preparation
US3689571A (en) * 1970-07-31 1972-09-05 Baxter Laboratories Inc Fluorinated ether
GB1499818A (en) * 1974-12-06 1978-02-01 Ici Ltd Anaesthetic composition
US4250334A (en) * 1979-12-26 1981-02-10 Baxter Travenol Laboratories, Inc. Method of synthesizing fluoromethylhexafluoroisopropyl ether
US4469898A (en) * 1979-12-26 1984-09-04 Baxter Travenol Laboratories, Inc. Method of synthesizing fluoromethylhexafluoroisopropyl ether
JP2786108B2 (ja) 1994-03-31 1998-08-13 セントラル硝子株式会社 フルオロメチル−1,1,1,3,3,3−ヘキサフルオロイソプロピルエーテルの精製方法
IT1270239B (it) * 1994-06-17 1997-04-29 Zambon Spa Composizione farmaceutica solida contenente acido (s)-2-(4- isobutilfenil) propionico come principio attivo
US5990176A (en) * 1997-01-27 1999-11-23 Abbott Laboratories Fluoroether compositions and methods for inhibiting their degradation in the presence of a Lewis acid

Also Published As

Publication number Publication date
DE69800928D1 (de) 2001-07-19
ES2170474T3 (es) 2002-08-01
SK284243B6 (sk) 2004-12-01
US20020016373A1 (en) 2002-02-07
CN1321958C (zh) 2007-06-20
CA2626424A1 (en) 1998-07-30
US6288127B1 (en) 2001-09-11
AR057610A2 (es) 2007-12-05
CN1899271A (zh) 2007-01-24
US20040048932A1 (en) 2004-03-11
BG109751A (bg) 2008-06-30
BG103656A (en) 2000-04-28
PL334477A1 (en) 2000-02-28
AU726733B2 (en) 2000-11-16
EP1114641A3 (en) 2003-05-28
BG65414B1 (bg) 2008-07-31
KR100368672B1 (ko) 2003-01-24
DK0967975T3 (da) 2001-09-17
CZ297092B6 (cs) 2006-09-13
SK86199A3 (en) 2000-06-12
US20030130359A1 (en) 2003-07-10
PT967975E (pt) 2001-11-30
JP3183520B2 (ja) 2001-07-09
NZ335994A (en) 2000-08-25
JP2005279283A (ja) 2005-10-13
CZ256199A3 (cs) 1999-11-17
US5990176A (en) 1999-11-23
DE69833884D1 (de) 2006-05-11
PT1114641E (pt) 2006-05-31
EP0967975B1 (en) 2001-06-13
US20060148906A1 (en) 2006-07-06
JP3664648B2 (ja) 2005-06-29
IL130150A0 (en) 2001-03-19
ZA98418B (en) 1999-04-20
CA2278133C (en) 2001-06-26
DE69800928T2 (de) 2001-11-22
EP0967975A1 (en) 2000-01-05
DE69833884T2 (de) 2006-08-24
HUP0002101A3 (en) 2002-03-28
NO993606D0 (no) 1999-07-23
US6677492B2 (en) 2004-01-13
ATE201987T1 (de) 2001-06-15
TR199901579T2 (xx) 1999-12-21
CN1244797A (zh) 2000-02-16
US6444859B2 (en) 2002-09-03
NO993606L (no) 1999-09-24
JP2000510159A (ja) 2000-08-08
EP1114641A2 (en) 2001-07-11
ATE320798T1 (de) 2006-04-15
AR011090A1 (es) 2000-08-02
AU5930098A (en) 1998-08-18
GR3036190T3 (en) 2001-10-31
HK1074434A1 (en) 2005-11-11
CN1152674C (zh) 2004-06-09
CA2278133A1 (en) 1998-07-30
CO4920220A1 (es) 2000-05-29
ES2256104T3 (es) 2006-07-16
KR20000070482A (ko) 2000-11-25
JP2006137769A (ja) 2006-06-01
BR9806996A (pt) 2000-03-14
EP1114641B1 (en) 2006-03-22
HUP0002101A2 (hu) 2001-05-28
WO1998032430A1 (en) 1998-07-30
JP2006143742A (ja) 2006-06-08
IL130150A (en) 2004-09-27
JP2001187729A (ja) 2001-07-10
CN1560003A (zh) 2005-01-05

Similar Documents

Publication Publication Date Title
DK1114641T3 (da) Fluorethersammensætninger og metoder til inhibering af deres nedbrydning i nærværelse af en Lewis-syre
DK1148875T3 (da) Fremgangsmåder og sammensætninger til forögelse af antallet af hvide blodlegemer
DK1109453T3 (da) Sammensætninger og fremgangsmåder til behandling af mitokondrielle sygdomme
NO20013393D0 (no) Brönnsementeringsfremgangsmåter og sammensetninger
DK0785770T3 (da) Sammensætninger til bekæmpelse af hæmorroider og fremgangsmåde til anvendelse deraf
DK0969846T3 (da) Sammensætninger og fremgangsmåder til reduktion af okulær hypertension
DK0980240T3 (da) Sammensætninger med lang frigivelse og fremgangsmåde til fremstilling heraf
DK1242095T3 (da) Antimikrobielle sammensætninger og fremgangsmåder til anvendelse deraf
NO20016277L (no) Systemer og fremgangsmåter for aerolisering av farmasöytiske sammensetninger
NO20012097D0 (no) Fremgangsmåter og sammensetninger for forebygging av toleranse overfor medisineringer
NO20003096D0 (no) Sammensetninger og fremgangsmÕter for behandling av ADD
NO20005828D0 (no) Herdbare punktfluidsammensetninger og fremgangsmåter
NO973046D0 (no) Elastiske sementsammensetninger og fremgangsmåte
DK1105122T3 (da) Pharmaceutical compositions containing lipase inhibitors
DK0946190T3 (da) Fremgangsmåder og sammensætninger til stimulering af neuritvækst
NO994216L (no) Sementsammensetninger og bionedbrytbare dispergeringsmidler derfor
DK1112174T3 (da) Isosorbidholdige polyestere og fremgangsmåder til fremstiling heraf
FI20000155L (fi) Karstaa ja/tai korroosiota estävä koostumus
NO20003067D0 (no) Antipicornavirus-forbindelser og fremgangsmÕter for deres anvendelse og fremstilling
PT1139761E (pt) Composicoes herbicidas e concentrados tensioactivos
DK0977812T3 (da) Asfaltsammensætninger og fremgangsmåder til fremstilling deraf
NO984761D0 (no) Aminoisokinoliner og aminotienopyridinderivater og deres anvendelse som antiinflammatoriske midler
NO20000425D0 (no) Collagen type I og type III klebende sammensetninger
NO985385L (no) Bitumensammensetninger og fremgangsmÕte for fremstilling derav
DE69837482D1 (de) Entschäumende zusammensetzungen